Suggestions
Brigham Hyde
CEO - Atropos Health
Brigham Hyde is a highly accomplished professional in the healthcare and data-driven industries, with a strong focus on evidence-based insights for improving health outcomes.
Dr. Hyde holds a Ph.D. in Pharmacology and Experimental Therapeutics from Tufts University School of Medicine, complemented by a BS in Chemistry from Northeastern University and a foundation from Stowe High School.
His career highlights include executive roles such as Chief Executive Officer at Atropos Health and President at EVERSANA, showcasing his leadership and strategic acumen within the healthcare sector.
Throughout his career, Brigham has also been actively involved in various organizations, serving as a Venture Partner at Audere Capital LLC, Partner at SymphonyAI, and Chief Data Officer at Decision Resources, among other esteemed positions.
His contributions extend to academia as well, with roles such as Adjunct Professor of Pharmacology and Experimental Therapeutics at Tufts University, demonstrating his commitment to shaping the next generation of healthcare professionals.
Dr. Hyde's expertise spans from equity research analysis at Cowen and Company to post-doctoral research at Boston University Medical Center, reflecting his diverse skill set and adaptability across different domains.
His entrepreneurial spirit is evident through founding and leading companies like Precision Health AI (now Concerto Health AI) and Relay Technology Management, Inc., where he served as Chief Executive Officer and Managing Director, respectively.
Brigham's extensive experience also includes strategic advisory roles at organizations like EVERSANA and Forbes, underscoring his influence and expertise in guiding business decisions in the rapidly evolving healthcare landscape.
Overall, Brigham Hyde's rich professional background, leadership roles, academic contributions, and entrepreneurial ventures position him as a prominent figure in the intersection of healthcare, data analytics, and innovation.
Highlights
A big day for Atropos Health yesterday. As the Gen AI hype bubble in Healthcare begins to shift, the focus is going to be on Quality, Accuracy, and Transparency. The core of Atropos is producing high-quality research-grade evidence with great automation and speed paired with quality, accuracy, and transparency physicians and researchers can trust. By doing this we are beginning to solve the Evidence Gap that has hampered effective clinical decision-making. The 40-year dream of a learning health system and personalized evidence-based medicine is feeling closer every day. Come and join us in this mission, and reach out to find out how Atropos is building infrastructure and user experiences that can be leveraged by all stakeholders in the healthcare ecosystem.
A special thanks to my cofounders Nigam Shah and Saurabh Gombar for your shared vision and incredible partnership. Also to our Day 1 team members who have led the approach to building this amazing platform Neil Sanghavi Yen Sia Low, PhD Vladimir Polony Rehan Chawdry Uday Reddy Alison Callahan. Also to all of our Day 1 investors, but in particular Matt Bettonville and Jim Breyer for your leadership and guidance.
Lastly, a big welcome to our new investors and partners Mike Spadafore Joel Krikston Kindra Tatarsky Michelle Snyder and Corey Lenhoff. It is incredibly exciting to have such a strong group of partners including Valtruis McKesson Ventures Cencora Merck at the table with us for this next phase.
Stay tuned, much more to come.
#vive2024 here we come. Great discussion below with SEQSTER ⬥ Ardy Arianpour ⬥ on how One-click Registries now meets One-Click Evidence. We are all in a new paradigm here, these are not years-long projects anymore. All of this means more evidence for care, more rapidly, and at higher quality. For life science partners this is a really important piece of data and evidence generation strategy to consider. These efforts don't need years-long deployments. What could it mean to your business to generate high-quality evidence in days to drive R&D and Commercial/Medical initiatives? If you are at Vive we are hosting a private event Sunday Night in LA, DM me for details.
